Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
5,830
-335
-5% -$74.3K 0.34% 46
2025
Q4
$1.41M Buy
6,165
+1,018
+20% +$232K 0.43% 39
2025
Q3
$1.19M Sell
5,147
-139
-3% -$28.3K 0.4% 45
2025
Q2
$981K Buy
5,286
+329
+7% +$61.1K 0.37% 49
2025
Q1
$1.04M Sell
4,957
-500
-9% -$97.2K 0.44% 46
2024
Q4
$970K Hold
5,457
0.45% 46
2024
Q3
$1.08M Hold
5,457
0.51% 44
2024
Q2
$936K Hold
5,457
0.5% 41
2024
Q1
$994K Sell
5,457
-200
-4% -$34.5K 0.59% 36
2023
Q4
$877K Sell
5,657
-200
-3% -$29.2K 0.55% 36
2023
Q3
$873K Sell
5,857
-200
-3% -$29.4K 0.59% 34
2023
Q2
$816K Buy
6,057
+200
+3% +$29.3K 0.54% 36
2023
Q1
$933K Sell
5,857
-200
-3% -$30.6K 0.76% 30
2022
Q4
$979K Hold
6,057
0.61% 33
2022
Q3
$813K Sell
6,057
-403
-6% -$57.8K 0.54% 39
2022
Q2
$989K Sell
6,460
-182
-3% -$27.8K 0.57% 40
2022
Q1
$1.08M Sell
6,642
-292
-4% -$42.4K 0.53% 39
2021
Q4
$939K Sell
6,934
-223
-3% -$26.3K 0.47% 42
2021
Q3
$772K Sell
7,157
-108
-1% -$12.3K 0.44% 46
2021
Q2
$830K Sell
7,265
-99
-1% -$11.2K 0.52% 38
2021
Q1
$792K Buy
7,364
+1,140
+18% +$122K 0.48% 41
2020
Q4
$698K Buy
+6,224
New +$598K 0.53% 42

Other funds holding ABBV

COWA LLC's ABBV Position: Q1 2026 in Review

COWA LLC reduced its AbbVie (ABBV) stake by 5.4% in Q1 2026, selling an estimated $74.3K and leaving 5,830 shares worth $1.27M. The position accounts for 0.34% of the portfolio, ranked #46.

COWA LLC first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.41M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • COWA LLC held 5,830 shares of AbbVie worth $1.27M as of Q1 2026.
  • COWA LLC sold 335 AbbVie shares in Q1 2026, an estimated $74.3K.
  • AbbVie made up 0.34% of COWA LLC's portfolio in Q1 2026, its #46 holding.
  • COWA LLC first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • COWA LLC's AbbVie position peaked at $1.41M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on COWA LLC's 13F filing for Q1 2026, filed 14 May 2026.